Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
51.68
-3.96 (-7.12%)
At close: Mar 28, 2025, 4:00 PM
49.86
-1.82 (-3.52%)
Pre-market: Mar 31, 2025, 8:08 AM EDT

Nutex Health Statistics

Total Valuation

Nutex Health has a market cap or net worth of $280.98 million. The enterprise value is $537.31 million.

Market Cap 280.98M
Enterprise Value 537.31M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, after market close.

Earnings Date May 7, 2025
Ex-Dividend Date n/a

Share Statistics

Nutex Health has 5.44 million shares outstanding. The number of shares has increased by 10.96% in one year.

Current Share Class 5.44M
Shares Outstanding 5.44M
Shares Change (YoY) +10.96%
Shares Change (QoQ) +2.62%
Owned by Insiders (%) 35.95%
Owned by Institutions (%) 16.77%
Float 3.26M

Valuation Ratios

PE Ratio n/a
Forward PE 87.59
PS Ratio 0.86
Forward PS 0.82
PB Ratio 4.46
P/TBV Ratio 9.16
P/FCF Ratio 13.88
P/OCF Ratio 13.18
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.84, with an EV/FCF ratio of 26.55.

EV / Earnings n/a
EV / Sales 1.84
EV / EBITDA 14.84
EV / EBIT 19.48
EV / FCF 26.55

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 3.80.

Current Ratio 1.77
Quick Ratio 1.68
Debt / Equity 3.80
Debt / EBITDA 8.06
Debt / FCF 14.98
Interest Coverage 1.44

Financial Efficiency

Return on equity (ROE) is -35.10% and return on invested capital (ROIC) is 4.23%.

Return on Equity (ROE) -35.10%
Return on Assets (ROA) 3.76%
Return on Invested Capital (ROIC) 4.23%
Return on Capital Employed (ROCE) 7.44%
Revenue Per Employee $365,000
Profits Per Employee -$51,418
Employee Count 800
Asset Turnover 0.64
Inventory Turnover 83.28

Taxes

In the past 12 months, Nutex Health has paid $2.87 million in taxes.

Income Tax 2.87M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +237.78% in the last 52 weeks. The beta is 2.22, so Nutex Health's price volatility has been higher than the market average.

Beta (5Y) 2.22
52-Week Price Change +237.78%
50-Day Moving Average 51.72
200-Day Moving Average 28.50
Relative Strength Index (RSI) 48.16
Average Volume (20 Days) 44,444

Short Selling Information

The latest short interest is 60,318, so 1.11% of the outstanding shares have been sold short.

Short Interest 60,318
Short Previous Month 50,404
Short % of Shares Out 1.11%
Short % of Float 1.85%
Short Ratio (days to cover) 1.28

Income Statement

In the last 12 months, Nutex Health had revenue of $292.00 million and -$41.13 million in losses. Loss per share was -$8.58.

Revenue 292.00M
Gross Profit 86.22M
Operating Income 27.58M
Pretax Income -39.95M
Net Income -41.13M
EBITDA 36.20M
EBIT 27.58M
Loss Per Share -$8.58
Full Income Statement

Balance Sheet

The company has $46.91 million in cash and $303.24 million in debt, giving a net cash position of -$256.33 million or -$47.15 per share.

Cash & Cash Equivalents 46.91M
Total Debt 303.24M
Net Cash -256.33M
Net Cash Per Share -$47.15
Equity (Book Value) 79.78M
Book Value Per Share 11.59
Working Capital 52.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $21.32 million and capital expenditures -$1.08 million, giving a free cash flow of $20.24 million.

Operating Cash Flow 21.32M
Capital Expenditures -1.08M
Free Cash Flow 20.24M
FCF Per Share $3.72
Full Cash Flow Statement

Margins

Gross margin is 29.53%, with operating and profit margins of 9.45% and -14.09%.

Gross Margin 29.53%
Operating Margin 9.45%
Pretax Margin -10.12%
Profit Margin -14.09%
EBITDA Margin 12.40%
EBIT Margin 9.45%
FCF Margin 6.93%

Dividends & Yields

Nutex Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.96%
Shareholder Yield n/a
Earnings Yield -14.64%
FCF Yield 7.20%

Analyst Forecast

The average price target for Nutex Health is $67.50, which is 30.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target $67.50
Price Target Difference 30.61%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 3, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jul 3, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

Nutex Health has an Altman Z-Score of -0.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.18
Piotroski F-Score 6